According to the Centers for Disease Control and Prevention (CDC), COVID cases and hospitalizations are on the rise. COVID-19 infection and hospitalization rates have begun to rise across USA & Canada as summer winds down into September, just as they have every autumn since 2020
Introducing Eris, the UK’s latest revelation – a novel variant known as EG.5.1, stemming from the Omicron lineage. Emerging in May, Eris swiftly spread across continents, leaving her mark in Europe, Asia, and North America. As Japan faces its “ninth wave” of infections, Eris takes center stage in the UK.
Gene Bio Medical is delighted to announce its selection as the commercialization business partner for a groundbreaking research initiative spearheaded by Professor Peter Unrau, an esteemed expert in RNA biochemistry from Simon Fraser University’s (SFU) Department of Molecular Biology and Biochemistry.
After COVID-19 and RSV, another novel virus is rapidly spreading throughout the United States.
According to the Centers for Disease Control and Prevention’s (CDC) Respiratory Virus Surveillance System, an unfamiliar and potentially dangerous virus called Human Metapneumovirus (HMPV) has been causing significant disruption in ICUs and pediatric hospitals across the nation since this spring.
Community Now! is a magazine created by, for, and about the community. It serves as a valuable resource to encourage curiosity, spark change, and facilitate connections. Education, business, mental health, and all generations intersect and foster innovation within our community. In addition, the magazine also features information about Gene Bio Medical company.
It is with great pleasure that we announce Gene Biotechnology Enterprises Ltd as an executive commercialization partner of the CBRF PRAIRIE Hub, which is spearheaded by the University of Alberta, University of Calgary, and University of Saskatchewan/VIDO.
The United Kingdom’s technology-based sectors create opportunities for Canadian companies
The United Kingdom is Canada’s most important science, technology and innovation (STI) partner in Europe. This importance is underscored in the comprehensive Canada-U.K. Memorandum of Understanding to facilitate further bilateral STI cooperation.
Gene Bio Medical is dedicated to the research & development and manufacturing of high-precision, low-cost and rapid diagnostic technologies that improve human health and response capabilities towards a variety of diseases.
RSV is the leading cause of bronchiolitis—inflammation of the lung’s small airways. In infants, and the virus is so common that nearly all children have encountered it by their second birthday.
540-6388 No.3 Road, Richmond, B.C., Canada V6Y 2B3
+1 (604) 370 0166
info@genebiomedical.com